Celgene (NASDAQ:CELG)

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Stocks were indicated to open lower on Monday after hitting all-time highs last week. With the bull market now nearing nine years old, the one trend that has prevailed for ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Alphabet, Amazon, Celgene, First Solar, Intel, IBM, Microsoft, Tesla, Twitter and More

Stocks were indicated higher on Friday morning after strong earnings reports came from key stocks and after gross domestic product was higher than expected at 3.0%. The trend that has ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

October 26, 2017: The S&P 500 closed up 0.13% at 2,560.37. The DJIA closed up 0.3% at 23,400.14. Separately, the Nasdaq was slightly down 0.1% at 6,556.77. Thursday was relatively positive ...
Read Full Story »

Celgene, General Electric Flop into Thursday’s 52-Week Low Club

October 26, 2017: Here are four stocks trading with heavy volume among 111 equities making new 52-week lows in Thursday's session. On the NYSE, advancers led decliners by about 8 ...
Read Full Story »

Why Celgene Sank to New Low Despite Q3 Earnings Beat

Celgene Corp. (NASDAQ: CELG) reported its most recent quarterly results before the markets opened on Thursday. Despite mixed results, with earnings were fairly positive for the quarter, this was not ...
Read Full Story »

Short Sellers Chase Biotechs Higher

The short interest data are out for the most recent settlement date, October 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Third-quarter earnings reporting season is now well under way. So far, things are looking good. The health care sector has yet to see any significant earnings representation, but that will ...
Read Full Story »

Friday’s Biggest Winners and Losers in the S&P 500

October 20, 2017: The S&P 500 closed up 0.5% at 2,575.03. The DJIA closed up 0.7% at 23,326.98. Separately, the Nasdaq was up 0.36% at 6,629.05. Friday was a very ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal, Stratasys and More

Stocks have hit new highs this week and went over 23,000 for the first time. Even after a weak opening on Thursday, the market managed to come back, and shares ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix, UnitedHealth and Many More

Stocks hit a new high on Monday, and they were indicated to open slightly higher on Tuesday. The Dow is now knocking on 23,000's door, and this bull market is ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, September 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

October 5, 2017: The S&P 500 closed up 0.6% at 2,552.10. The DJIA closed up 0.5% at 22,775.80. Separately, the Nasdaq was up 0.8% at 6,585.36. Thursday was another strong ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Jefferies Red-Hot Tech and Biotech Growth Stocks to Buy Now

With the fourth quarter right around the corner and earnings season ready to rev back up, many investors are shuffling their portfolio for the stretch run of 2017. While it ...
Read Full Story »